| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EIC | 9.29 | 0.41 | +4.62% |
| Eagle Point Income Company | |||
| XLFX | 30.88 | 0.44 | +1.43% |
| Corgi U.S. Financials 2x Daily ETF (XLFX) | |||
| FTXH | 44.23 | 0.08 | +0.18% |
| First Trust Nasdaq Pharmaceuticals ETF (FTXH) | |||
| QARP | 69.80 | -0.05 | -0.07% |
| Xtrackers Russell 1000 US Quality at a Reasonable Price ETF (QARP) | |||
| QSIX | 39.89 | -0.47 | -1.15% |
| Pacer Metaurus Nasdaq 100 Dividend Multiplier 600 ETF (QSIX) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QSIX | 39.89 | -0.47 | -1.15% |
| Pacer Metaurus Nasdaq 100 Dividend Multiplier 600 ETF (QSIX) | |||
| QARP | 69.80 | -0.05 | -0.07% |
| Xtrackers Russell 1000 US Quality at a Reasonable Price ETF (QARP) | |||
| FTXH | 44.23 | 0.08 | +0.18% |
| First Trust Nasdaq Pharmaceuticals ETF (FTXH) | |||
| XLFX | 30.88 | 0.44 | +1.43% |
| Corgi U.S. Financials 2x Daily ETF (XLFX) | |||
| EIC | 9.29 | 0.41 | +4.62% |
| Eagle Point Income | |||
A.I.dvisor tells us that XLCI and JEPI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLCI and JEPI's prices will move in lockstep.
| Ticker / NAME | Correlation To XLCI | 1D Price Change % | ||
|---|---|---|---|---|
| XLCI | 100% | +0.96% | ||
| JEPI - XLCI | 22% Poorly correlated | -0.29% | ||
| SPYI - XLCI | 21% Poorly correlated | -0.19% | ||
| DIVO - XLCI | 20% Poorly correlated | -0.38% | ||
| QQQI - XLCI | -7% Poorly correlated | -0.25% | ||
| JEPQ - XLCI | -8% Poorly correlated | -0.26% | ||
More | ||||
The RSI Oscillator for XLCI moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 10 similar instances when the indicator left oversold territory. In 9 of the 10 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on XLCI as a result. In 16 of 24 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for XLCI just turned positive on November 06, 2026. Looking at past instances where XLCI's MACD turned positive, the stock continued to rise in 8 of 11 cases over the following month. The odds of a continued upward trend are 73%.
XLCI moved above its 50-day moving average on November 13, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLCI advanced for three days, in 38 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
XLCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for XLCI crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for XLCI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.